Post-translational and activation-dependent modifications of the G protein-coupled thrombin receptor - PubMed (original) (raw)
. 1995 Apr 7;270(14):8367-72.
doi: 10.1074/jbc.270.14.8367.
Affiliations
- PMID: 7713946
- DOI: 10.1074/jbc.270.14.8367
Free article
Post-translational and activation-dependent modifications of the G protein-coupled thrombin receptor
V Vouret-Craviari et al. J Biol Chem. 1995.
Free article
Abstract
The purpose of the present study was to analyze the post-translational and activation-dependent modifications of the G protein-coupled thrombin receptor. A human receptor cDNA was engineered to encode an epitope tag derived from the vesicular stomatitis virus glycoprotein at the COOH terminus of the receptor and expressed in human embryonic kidney 293 cells. We show here that the mature receptor is a glycosylated protein with an apparent molecular mass ranging from 68 to 80 kDa by SDS-polyacrylamide gel electrophoresis. Removal of asparagine-linked oligosaccharides with N-glycosidase F leads to the appearance of a 36-40-kDa receptor species. The current model for receptor activation by thrombin involves specific hydrolysis of the arginine-41/serine-42 (Arg-41/Ser-42) peptide bond. Cleavage of the receptor by thrombin was demonstrated directly by Western analyses performed on membranes and glycoprotein-enriched lysates from transfected cells. Whereas thrombin treatment of cells results in increased mobility of the receptor in SDS-polyacrylamide gel electrophoresis, we found that their treatment with the thrombin receptor agonist peptide leads to a decrease in thrombin receptor mobility due, in part, to phosphorylation. The serine proteases trypsin and plasmin also cleave and activate the receptor similar to thrombin, whereas chymotrypsin cleaves the receptor at a site distal to Arg-41, thus rendering it unresponsive to thrombin while still responsive to thrombin receptor agonist peptide.
Similar articles
- Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, Costello CE. Kuliopulos A, et al. Biochemistry. 1999 Apr 6;38(14):4572-85. doi: 10.1021/bi9824792. Biochemistry. 1999. PMID: 10194379 - Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D, Perrault C, Morales M, Moog S, Ravanat C, Schuhler S, Arcone R, Pietropaolo C, Cazenave JP, van Dorsselaer A, Lanza F. Loew D, et al. Biochemistry. 2000 Sep 5;39(35):10812-22. doi: 10.1021/bi0003341. Biochemistry. 2000. PMID: 10978167 - Thrombin primes responsiveness of selective chemoattractant receptors at a site distal to G protein activation.
Ali H, Tomhave ED, Richardson RM, Haribabu B, Snyderman R. Ali H, et al. J Biol Chem. 1996 Feb 9;271(6):3200-6. doi: 10.1074/jbc.271.6.3200. J Biol Chem. 1996. PMID: 8621721 - Thrombin receptors: turning them off after turning them on.
Brass LF, Ahuja M, Belmonte E, Blanchard N, Pizarro S, Tarver A, Hoxie JA. Brass LF, et al. Semin Hematol. 1994 Jul;31(3):251-60. Semin Hematol. 1994. PMID: 7973781 Review. - The thrombin receptor.
Dennington PM, Berndt MC. Dennington PM, et al. Clin Exp Pharmacol Physiol. 1994 May;21(5):349-58. doi: 10.1111/j.1440-1681.1994.tb02527.x. Clin Exp Pharmacol Physiol. 1994. PMID: 7955544 Review.
Cited by
- Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.
Schuepbach RA, Feistritzer C, Brass LF, Riewald M. Schuepbach RA, et al. Blood. 2008 Mar 1;111(5):2667-73. doi: 10.1182/blood-2007-09-113076. Epub 2007 Dec 18. Blood. 2008. PMID: 18089851 Free PMC article. - Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2.
Corvera CU, Déry O, McConalogue K, Böhm SK, Khitin LM, Caughey GH, Payan DG, Bunnett NW. Corvera CU, et al. J Clin Invest. 1997 Sep 15;100(6):1383-93. doi: 10.1172/JCI119658. J Clin Invest. 1997. PMID: 9294103 Free PMC article. - Variable-Temperature Native Mass Spectrometry for Studies of Protein Folding, Stabilities, Assembly, and Molecular Interactions.
Laganowsky A, Clemmer DE, Russell DH. Laganowsky A, et al. Annu Rev Biophys. 2022 May 9;51:63-77. doi: 10.1146/annurev-biophys-102221-101121. Epub 2021 Dec 21. Annu Rev Biophys. 2022. PMID: 34932911 Free PMC article. Review. - YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC, Huang SW, Hwang TL, Kuo SC, Lee FY, Teng CM. Wu CC, et al. Br J Pharmacol. 2000 Jul;130(6):1289-96. doi: 10.1038/sj.bjp.0703437. Br J Pharmacol. 2000. PMID: 10903968 Free PMC article. - Cell surface remodeling by plasmin: a new function for an old enzyme.
Deryugina EI, Quigley JP. Deryugina EI, et al. J Biomed Biotechnol. 2012;2012:564259. doi: 10.1155/2012/564259. Epub 2012 Oct 14. J Biomed Biotechnol. 2012. PMID: 23097597 Free PMC article. Review.